Effect of dietary phenylalanine on the plasma concentrations of phenylalanine, phenylethylamine and phenylacetic acid in healthy volunteers.
1. Phenylethylamine has been proposed as a neuromodulator in several psychiatric and other brain disorders, and its concentration and that of its major metabolite, phenylacetic acid, in plasma may prove useful as state or trait markers in diagnosis, treatment or in the elucidation of biochemical mechanisms of these disorders. 2. The effect of dietary phenylalanine intake and changes in dietary phenylalanine intake on the plasma concentrations and changes in plasma concentrations, respectively, of phenylalanine, phenylethylamine and unconjugated and conjugated phenylacetic acid have been investigated. 3. Dietary phenylalanine affects the concentration of plasma phenylalanine on the following day, but has no effect on phenylethylamine or phenylacetic acid concentrations. Thus single measurements per subject of phenylethylamine or phenylacetic acid do not need to take dietary factors into account. 4. Changes in dietary phenylalanine (whether in absolute amount or in the proportion of phenylalanine in the diet) are significantly correlated with changes in unconjugated phenylacetic acid. Therefore, in longitudinal studies, dietary factors should be taken into account.
Davis
B A
BA
Neuropsychiatric Research Unit, University of Saskatchewan, Saskatoon, Canada.
O'Reilly
R L
RL
Placatka
C L
CL
Paterson
I A
IA
Yu
P H
PH
Durden
D A
DA
D000328:Adult; D004032:Diet; D005260:Female; D006801:Humans; D008297:Male; D010627:Phenethylamines / Q000097:blood*; D010648:Phenylacetates / Q000097:blood*; D010649:Phenylalanine / Q000097:blood* / Q000494:pharmacology; D012016:Reference Values; D012044:Regression Analysis
D010627:Phenethylamines; D010648:Phenylacetates; C029261:phenethylamine; D010649:Phenylalanine; C025136:phenylacetic acid